LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMFA08020234
|
N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide
|
N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide
|
|
C29H55N3O3
|
493.424342
|
LMFA08020235
|
(E)-15-methyl-N,N-bis(4-pentanamidobutyl)hexadec-6-enamide
|
15-methyl-N,N-bis(4-pentanamidobutyl)hexadec-6E-enamide
|
|
C35H67N3O3
|
577.518242
|
LMFA08020238
|
N-(3-oxo-heptanoyl)-homoserine thiolactone
|
N-(3-oxo-heptanoyl)-homoserine thiolactone
|
|
C11H17NO3S
|
243.092916
|
LMFA08020239
|
N-(3-oxo-octanoyl)-homoserine thiolactone
|
N-(3-oxo-octanoyl)-homoserine thiolactone
|
|
C12H19NO3S
|
257.108566
|
LMFA08020240
|
N-(3-oxo-hexanoyl)-homoserine thiolactone
|
N-(3-oxo-hexanoyl)-homoserine thiolactone
|
|
C10H15NO3S
|
229.077266
|
LMFA08020241
|
N-(3-oxo-dodecanoyl)-homoserine thiolactone
|
N-(3-oxo-dodecanoyl)-homoserine thiolactone
|
|
C16H27NO3S
|
313.171166
|
LMFA08020243
|
alpha-N-(3-(11,12-methylene)-octadecanoyloxy-hexadecanoyl)-L-ornithine
|
(2S)-5-amino-2-(3-(11,12-methylene-octadecanoyloxy)-hexadecanamido) pentanoic acid
|
|
C40H76N2O5
|
664.575423
|
LMFA08020244
|
alpha-N-(3-(3-hydroxy-11,12-methylene-octadecanoyloxy)-hexadecanoyl)-L-ornithine
|
(2S)-5-amino-2-(3-(3-hydroxy-11,12-methylene-octadecanoyloxy) hexadecanamido) pentanoic acid
|
|
C40H76N2O6
|
680.570338
|
LMFA08020245
|
N-palmitoyl dopamine
|
N-[2-(3,4-dihydroxyphenyl)ethyl]-9Z-hexadecenamide
|
NA 24:5;O2
|
C24H39NO3
|
389.292994
|
LMFA08020246
|
N-stearoyl dopamine
|
N-[2-(3,4-dihydroxyphenyl)ethyl]-octadecanamide
|
NA 26:4;O2
|
C26H45NO3
|
419.339944
|
LMFA08020247
|
N-margaroyl taurine
|
N-heptadecanoyl taurine
|
NAT 17:0
|
C19H39NO4S
|
377.259981
|
LMFA08020248
|
N-nonadecanoyl taurine
|
N-nonadecanoyl taurine
|
NAT 19:0
|
C21H43NO4S
|
405.291281
|
LMFA08020249
|
N-arachidoyl taurine
|
N-eicosanoyl taurine
|
NAT 20:0
|
C22H45NO4S
|
419.306931
|
LMFA08020250
|
N-heneicosanoyl taurine
|
N-heneicosanoyl taurine
|
NAT 21:0
|
C23H47NO4S
|
433.322581
|
LMFA08020251
|
N-tricosanoyl taurine
|
N-tricosanoyl taurine
|
NAT 23:0
|
C25H51NO4S
|
461.353881
|
LMFA08020252
|
N-lignoceroyl taurine
|
N-tetracosanoyl taurine
|
NAT 24:0
|
C26H53NO4S
|
475.369531
|
LMFA08020253
|
N-pentacosanoyl taurine
|
N-pentacosanoyl taurine
|
NAT 25:0
|
C27H55NO4S
|
489.385181
|
LMFA08020254
|
N-hexacosanoyl taurine
|
N-hexacosanoyl taurine
|
NAT 26:0
|
C28H57NO4S
|
503.400831
|
LMFA08020255
|
N-(9Z-nonadecenoyl) taurine
|
N-(9Z-nonadecenoyl) taurine
|
NAT 19:1
|
C21H41NO4S
|
403.275631
|
LMFA08020256
|
N-gondoyl taurine
|
N-(11Z-eicosenoyl) taurine
|
NAT 20:1
|
C22H43NO4S
|
417.291281
|
LMFA08020257
|
N-nervonoyl taurine
|
N-(15Z-tetracosenoyl) taurine
|
NAT 24:1
|
C26H51NO4S
|
473.353881
|
LMFA08020258
|
N-erucoyl taurine
|
N-(13Z-docosenoyl) taurine
|
NAT 22:1
|
C24H47NO4S
|
445.322581
|
LMFA08020259
|
N-(14Z-tricosenoyl) taurine
|
N-(14Z-tricosenoyl) taurine
|
NAT 23:1
|
C25H49NO4S
|
459.338231
|
LMFA08020266
|
N6-lauroyl lysine
|
N6-dodecanoyl lysine
|
|
C18H36N2O3
|
328.272593
|
LMFA08020268
|
N6-goshuyoyl lysine
|
N6-(5Z,8Z-tetradecadienoyl) lysine
|
|
C20H36N2O3
|
352.272593
|
LMFA08020269
|
N6-myristoyl lysine
|
N6-tetradecanoyl lysine
|
|
C20H40N2O3
|
356.303893
|
LMFA08020270
|
N-linoleoyl dopamine
|
N-(9Z,12Z-octadecadienoyl) dopamine
|
NA 26:6;O2
|
C26H41NO3
|
415.308644
|
LMFA08020271
|
N-linolenoyl dopamine
|
N-(9Z,12Z,15Z-octadecatrienoyl) dopamine
|
NA 26:7;O2
|
C26H39NO3
|
413.292994
|
LMFA08020272
|
Dihomo-gamma-linolenoyl dopamine
|
N-(8Z,11Z,14Z-eicosatrienoyl) dopamine
|
NA 28:7;O2
|
C28H43NO3
|
441.324294
|
LMFA08020273
|
N-gamma-linolenoyl dopamine
|
N-(6Z,9Z,12Z-octadecatrienoyl) dopamine
|
NA 26:7;O2
|
C26H39NO3
|
413.292994
|
LMFA08020274
|
N-(7Z,10Z,13Z-16Z-docosatetraenoyl) dopamine
|
N-(7Z,10Z,13Z-16Z-docosatetraenoyl) dopamine
|
NA 30:8;O2
|
C30H45NO3
|
467.339944
|
LMFA08020275
|
alpha-N-(3-hexadecanoyloxy-hexadecanoyl)-L-ornithine
|
(2S)-5-amino-2-(3-hexadecanoyloxy-hexadecanamido)pentanoic acid
|
|
C37H72N2O5
|
624.544123
|
LMFA08020276
|
Semiplenamide B
|
N-(2-methyl-2Z,6E-eicosadienoyl)-2-acetoxyethylamine
|
NA 25:3;O2
|
C25H45NO3
|
407.339944
|
LMFA08020277
|
Semiplenamide C
|
N-(2-methyl-2Z-hexadecenoyl)-1-hydroxypropyl-2(S)-amine
|
NA 20:1;O
|
C20H39NO2
|
325.298079
|
LMFA08020278
|
Semiplenamide D
|
N-(2-methyl-2Z-eicosenoyl)-1S-methyl-2-acetoxyethylamine
|
NA 26:2;O2
|
C26H49NO3
|
423.371244
|
LMFA08020279
|
Semiplenamide E
|
N-(2-methyl-2Z-octadecenoyl)-1S-methyl-2-acetoxyethylamine
|
NA 24:2;O2
|
C24H45NO3
|
395.339944
|
LMFA08020280
|
Semiplenamide G
|
N-(2-methyl-2S,3R-epoxy-octadecanoyl)-1-methyl-2-acetoxyethylamine
|
NA 24:2;O3
|
C24H45NO4
|
411.334859
|
LMFA08020281
|
Semiplenamide F
|
N-(2-methyl-2S,3R-epoxy-octadecanoyl)-1-hydroxypropyl-2-amine
|
NA 22:1;O2
|
C22H43NO3
|
369.324294
|
LMFA08020282
|
Granadaene
|
(2S)-5-amino-2-(27R-O-alpha-L-rhamnopyranosyl-2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E-octacosadodecaenoyl)pentanoic acid
|
|
C39H52N2O8
|
676.372368
|
LMFA08020283
|
|
N-3-hydroxy-13-methyl-hexadecanoyl glycyl-L-serine
|
|
C22H42N2O6
|
430.304288
|
LMFA08020284
|
Topostin B553
|
N-(3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycine
|
|
C33H63NO5
|
553.470624
|
LMFA08020285
|
Topostin D654
|
N-(15-methyl-3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycylserine
|
|
C37H70N2O7
|
654.518303
|
LMFA08020286
|
Topostin D654
|
N-(3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycylserine
|
|
C36H68N2O7
|
640.502653
|
LMFA08020287
|
|
N-(14-methyl-3S-(13-methyl-4Z-tetradecenoyloxy)-pentadecanoyl)-glycine
|
NA 33:3;O4
|
C33H61NO5
|
551.454974
|
LMFA08020288
|
Bacillamidin A
|
N-(9-methyldecanoyl)-dimethyaspartate
|
NA 17:2;O4
|
C17H31NO5
|
329.220224
|
LMFA08020289
|
Bacillamidin B
|
N-(10-methyldodecanoyl)-dimethyaspartate
|
NA 19:2;O4
|
C19H35NO5
|
357.251524
|
LMFA08020290
|
Bacillamidin D
|
N-[(3R)-1-(2-methylpropyl)-2,5-dioxopyrrolidin-3-yl]-9-methyldecanamide
|
|
C19H34N2O3
|
338.256943
|
LMFA08020291
|
Bacillamidin C
|
N-[(3R)-2,5-dioxopyrrolidin-3-yl]-10-methyldodecanamide
|
|
C17H30N2O3
|
310.225643
|
LMFA08020292
|
Bacillamidin E
|
N-[(2S,3S)-2-[(1S)-1-hydroxy-2-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-2-oxoethyl]-5-oxooxolan-3-yl]-13-methyltetradecanamide
|
|
C36H56N2O7
|
628.408753
|
LMFA08020297
|
Mutanamide
|
N-(3-oxo-decanoyloxy)-L-leucyl-L-alanine
|
|
C19H34N2O5
|
370.246773
|